Profile data is unavailable for this security.
About the company
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticala and Consumer Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Company is focusing on their oncology platform for Targeted Alpha Therapies for treating prostate cancer. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment has been moved to Cinven which operates as an independent company called Envu.
- Revenue in EUR (TTM)50.49bn
- Net income in EUR3.04bn
- LocationBayer AGKaiser-Wilhelm-Allee 1LEVERKUSEN 51373GermanyDEU
- Phone+49 214301
- Fax+49 2 143066328
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|BAYX.N:GER since |
|Blackford Analysis Ltd||Deal completed||18 Jan 2023||18 Jan 2023Deal completed||-10.28%||--|
|Targenomix GmbH||Deal completed||10 Nov 2022||10 Nov 2022Deal completed||1.77%||--|